Literature DB >> 9119063

Contributions of cloned type I interferon receptor subunits to differential ligand binding.

E C Cutrone1, J A Langer.   

Abstract

The human type I interferons, including at least 12 IFN-alphas, IFN-beta and IFN-omega, bind to a receptor (IFNAR) composed of at least two transmembrane subunits, IFNAR-1 and IFNAR-2. The contributions of the receptor subunits to ligand binding were investigated by measuring the binding properties of IFNAR-1 or IFNAR-2 alone, or when co-expressed. The affinity of IFNAR-2 for IFN-alpha2 was increased by the co-expression of IFNAR-1, which itself binds ligand very weakly. Most type I IFNs inhibited the binding of IFN-alpha2 to IFNAR-2 alone with IC50 values of 2-20 nM. For cells co-expressing IFNAR-1 and IFNAR-2, the IC50 values decreased 3-20-fold for various ligands, relative to their values on IFNAR-2 alone. Thus, while IFNAR-2 plays the major role in affinity determination and differential recognition of type I IFNs, IFNAR-1 modulates both the ligand affinity and selectivity of the IFNAR-1/IFNAR-2 receptor complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119063     DOI: 10.1016/s0014-5793(97)00129-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; C Lee; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Authors:  Yuhki Yamaguchi; Keisuke Hino; Daisuke Fujiwara; Fenyu Ren; Yoshiharu Katoh; Yasuhiro Satoh; Kiwamu Okita
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

4.  The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.

Authors:  M C Gauzzi; G Barbieri; M F Richter; G Uzé; L Ling; M Fellous; S Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection.

Authors:  Martynas Gavutis; Suman Lata; Peter Lamken; Pia Müller; Jacob Piehler
Journal:  Biophys J       Date:  2005-03-18       Impact factor: 4.033

6.  The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.

Authors:  Zongli Li; Jennifer Julia Strunk; Peter Lamken; Jacob Piehler; Thomas Walz
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

7.  Alteration of interferon-α/β receptors in chronic hepatitis B patients.

Authors:  Fanli Meng; Jiefei Wang; Jian Ge; Xiaopeng Fan; Bing Wang; Liyan Han; Tatiana Kisseleva; YongHan Paik; David A Brenner; Kai Wang
Journal:  J Clin Immunol       Date:  2011-03-29       Impact factor: 8.317

8.  The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.

Authors:  Narae Ahn; Woo-Jong Kim; Nari Kim; Han Wook Park; Seung-Woo Lee; Joo-Yeon Yoo
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.

Authors:  Diego A Jaitin; Laila C Roisman; Eva Jaks; Martynas Gavutis; Jacob Piehler; Jose Van der Heyden; Gilles Uze; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

10.  Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.

Authors:  Zrinka Marijanovic; Josiane Ragimbeau; José van der Heyden; Gilles Uzé; Sandra Pellegrini
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.